Ligand Pharmaceuticals (LGND) Return on Capital Employed Growth (5y) (2017 - 2026)
Ligand Pharmaceuticals (LGND) Return on Capital Employed Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 5.88 Bn | 5.10 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 317.00 |
| Dec 31, 2025 | -34.00 |
| Sep 30, 2025 | 111.00 |
| Jun 30, 2025 | -360.00 |
| Mar 31, 2025 | -596.00 |
| Dec 31, 2024 | -5,614.00 |
| Sep 30, 2024 | -5,373.00 |
| Jun 30, 2024 | -5,214.00 |
| Mar 31, 2024 | -6,797.00 |
| Dec 31, 2023 | -866.00 |
| Sep 30, 2023 | -1,401.00 |
| Jun 30, 2023 | -2,198.00 |
| Mar 31, 2023 | -1,817.00 |
| Dec 31, 2022 | -1,554.00 |
| Sep 30, 2022 | -753.00 |
| Jun 30, 2022 | -479.00 |
| Mar 31, 2022 | -130.00 |
| Jun 30, 2021 | -350.00 |
| Mar 31, 2021 | -404.00 |
| Dec 31, 2020 | -632.00 |